07:00 , Jun 29, 2015 |  BC Week In Review  |  Company News

IGXBio, Cannabis Science deal

The companies will combine Cannabis’ CS-TATI-1 with IGXBio’s GenePro to treat HIV infection. Cannabis will provide IGXBio with an undisclosed number of Cannabis shares in exchange for using GenePro in combined preclinical studies. CS-TATI-1 is...